医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Sialylation of TLR2 initiates osteoclast fusion

摘要The molecular control of osteoclast formation is still not clearly elucidated.Here,we show that a process of cell recognition mediated by Siglec1 5-TLR2 binding is indispensable and occurs prior to cell fusion in RANKL-mediated osteoclastogenesis.Siglec15 has been shown to regulate osteoclastic bone resorption.However,the receptor for Siglec1 5 has not been identified,and the signaling mechanism involving Siglec1 5 in osteoclast function remains unclear.We found that Siglec1 5 bound sialylated TLR2 as its receptor and that the binding of sialylated TLR2 to Siglec1 5 in macrophages committed to the osteoclast-lineage initiated cell fusion for osteoclast formation,in which sialic acid was transferred by the sialyltransferase ST3Gal1.Interestingly,the expression of Siglec1 5 in macrophages was activated by M-CSF,whereas ST3Gal1 expression was induced by RANKL.Both Siglec1 5-specific deletion in macrophages and intrafemoral injection of sialidase abrogated cell recognition and reduced subsequent cell fusion for the formation of osteoclasts,resulting in increased bone formation in mice.Thus,our results reveal that cell recognition mediated by the binding of sialylated TLR2 to Siglec1 5 initiates cell fusion for osteoclast formation.

更多
广告
作者 Ce Dou [1] Gehua Zhen [1] Yang Dan [1] Mei Wan [1] Nathachit Limjunyawong [2] Xu Cao [1] 学术成果认领
作者单位 Department of Orthopedic Surgery,Institute of Cell Engineering and Department of Biomedical Engineering,Johns Hopkins University School of Medicine,Baltimore,MD,USA [1] The Solomon H.Snyder Department of Neuroscience,Johns Hopkins University School of Medicine,Baltimore,MD,USA [2]
栏目名称
发布时间 2022-07-07(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览19
  • 下载6
骨研究(英文版)

骨研究(英文版)

2022年10卷2期

286-296页

SCIMEDLINECSCD

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷